LianBio (LIANY)
OTCMKTS
· Delayed Price · Currency is USD
0.195
-0.005 (-2.50%)
Jan 31, 2025, 4:00 PM EST
LianBio Market Cap
LianBio has a market cap or net worth of $21.12 million as of January 31, 2025. Its market cap has decreased by -95.65% in one year.
Market Cap
21.12M
Enterprise Value
-194.48M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.19
Market Cap Chart
Since November 1, 2021, LianBio's market cap has decreased from 1.44B to 21.12M, a decrease of -98.54%. That is a compound annual growth rate of -72.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 31, 2025 | 21.12M | -26.32% |
| Dec 31, 2024 | 28.66M | -94.07% |
| Dec 29, 2023 | 483.04M | 171.83% |
| Dec 30, 2022 | 177.70M | -73.10% |
| Dec 31, 2021 | 660.59M | -54.19% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Endo Inc. | 2.10B |
| SS Innovations International | 1.55B |
| Veradigm | 1.36B |
| Nika Pharmaceuticals | 1.02B |
| Elite Pharmaceuticals | 500.05M |
| Glass House Brands | 467.54M |
| Northwest Biotherapeutics | 366.55M |
| BioStem Technologies | 254.31M |